Rankings
▼
Calendar
NAUT FY 2021 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$3M
Operating Income
-$50M
Net Income
-$50M
EPS (Diluted)
$-0.60
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$42M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$398M
Total Liabilities
$35M
Stockholders' Equity
$364M
Cash & Equivalents
$186M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$3M
-$2M
-21.1%
Operating Income
-$50M
-$16M
-220.7%
Net Income
-$50M
-$16M
-222.1%
← Q4 2020
All Quarters
Q1 2021 →